HIV/AIDS Vaccines
Researchers describe findings in HIV/AIDS vaccines studies
Published in Vaccine Weekly, February 15th, 2006
Study 1: Gag-Env pseudovirion immunization induced neutralizing antibodies against human immunodeficiency virus type 1 primary isolates.
"A major challenge for the development of an effective HIV vaccine is to elicit neutralizing antibodies against a broad array of primary isolates. Monomeric gp120-based vaccine approaches have not been successful in inducing this type of response, prompting a number of approaches designed to recreate the native glycoprotein complex that exists on the viral membrane."
"Gag-Env pseudovirions are noninfectious...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-02-15)
More Articles from Vaccine Weekly
- Alzheimer Disease Vaccine
Study examined effects of epitopes and adjuvants on anti-Alzheimer DNA vaccine - Avian Influenza Vaccine
Research quantifies vaccination effect on transmission of avian influenza in chickens - Diabetes Vaccine
DNA vaccine prevents diabetes through enhanced beta cell proliferation - Herpes Vaccine
CpG ODN enhances HSV DNA vaccine efficacy against genital herpes - Vaccine Adjuvant
Vesiculated alpha-tocopheryl succinate enhances effect of dendritic cell vaccines - Addiction Medicine
Review examines future advances in addiction treatment - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
